Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Takeshi Hirota, Yuito Fujita & Ichiro Ieiri. (2020) An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins. Expert Opinion on Drug Metabolism & Toxicology 16:9, pages 809-822.
Read now
Read now
Brian Tomlinson, Paul Chan, Yuzhen Zhang, Zhongmin Liu & Christopher Wai Kei Lam. (2020) Pharmacokinetics of current and emerging treatments for hypercholesterolemia. Expert Opinion on Drug Metabolism & Toxicology 16:5, pages 371-385.
Read now
Read now
Paul Chan, Li Shao, Brian Tomlinson, Yuzhen Zhang & Zhong-Min Liu. (2019) An evaluation of pitavastatin for the treatment of hypercholesterolemia. Expert Opinion on Pharmacotherapy 20:1, pages 103-113.
Read now
Read now
Articles from other publishers (24)
Esmeralda Dautović, Monika Rustemović-Čorbić, Nahida Srabović, Adaleta Softić, Aida Smajlović, Maida Šljivić Husejnović, Alen Hatkić & Dalila Halilčević. (2023) Some pleiotropic effects of statins on hepatocellular carcinoma cells: Comparative study on atorvastatin, rosuvastatin and simvastatin. Advances in Medical Sciences 68:2, pages 258-264.
Crossref
Crossref
Avishay Elis. (2023) Current and future options in cholesterol lowering treatments. European Journal of Internal Medicine 112, pages 1-5.
Crossref
Crossref
Weirui Lei, Jiwen Hu, Yaqian Xie, Can Liu & Xuekun Chen. (2023) Mathematical modelling of the effects of statins on the growth of necrotic core in atherosclerotic plaque. Mathematical Modelling of Natural Phenomena 18, pages 11.
Crossref
Crossref
Yolanda Prado, Diego Aravena, Felipe M. Llancalahuen, Cristobal Aravena, Felipe Eltit, Cesar Echeverría, Sebastian Gatica, Claudia A. Riedel & Felipe Simon. 2023. Advances in Molecular Pathology. Advances in Molecular Pathology
25
47
.
Amir Tajbakhsh, Seyed Mohammad Gheibihayat, Hassan Askari, Amir Savardashtaki, Matteo Pirro, Thomas P. Johnston & Amirhossein Sahebkar. (2022) Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions. Pharmacology & Therapeutics 238, pages 108282.
Crossref
Crossref
Fatemeh Zahedipour, Alexandra E. Butler, Ali H. Eid & Amirhossein Sahebkar. (2022) Pleiotropic properties of statins via angiogenesis modulation in cardiovascular disease. Drug Discovery Today 27:10, pages 103325.
Crossref
Crossref
Weiwei Zeng, Miao Hu, Hon Kit Lee, Elaine Wat, Clara Bik San Lau, Chung Shun Ho, Chun Kwok Wong & Brian Tomlinson. (2022) Effect of Green Tea Extract and Soy Isoflavones on the Pharmacokinetics of Rosuvastatin in Healthy Volunteers. Frontiers in Nutrition 9.
Crossref
Crossref
Iveta Merćep, Ivana Radman, Vladimir Trkulja, Tamara Božina, Livija Šimičević, Ema Budimir, Lana Ganoci & Nada Božina. (2021) Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case–control study. European Journal of Clinical Pharmacology 78:2, pages 227-236.
Crossref
Crossref
Mazaher Ahmadi, Shayan Amiri, Stevan Pecic, Filip Machaj, Jakub Rosik, Marek J. Łos, Javad Alizadeh, Reza Mahdian, Simone C. da Silva Rosa, Dedmer Schaafsma, Shahla Shojaei, Tayyebeh Madrakian, Amir A. Zeki & Saeid Ghavami. (2020) Pleiotropic effects of statins: A focus on cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:12, pages 165968.
Crossref
Crossref
Hye Jee Hahn, Ruben Abagyan, Larissa M. Podust, Shantanu Roy, Ibne Karim M. Ali & Anjan Debnath. (2020)
HMG-CoA Reductase Inhibitors as Drug Leads against
Naegleria fowleri
. ACS Chemical Neuroscience 11:19, pages 3089-3096.
Crossref
Crossref
Cesare R Sirtori, Shizuya Yamashita, Maria Francesca Greco, Alberto Corsini, Gerald F Watts & Massimiliano Ruscica. (2019) Recent advances in synthetic pharmacotherapies for dyslipidaemias. European Journal of Preventive Cardiology 27:15, pages 1576-1596.
Crossref
Crossref
Shenjia Huang, Qingqing Xu, Linsheng Liu, Yicong Bian, Shichao Zhang, Chenrong Huang & Liyan Miao. (2020) Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin. Current Drug Metabolism 21:6, pages 471-478.
Crossref
Crossref
Hye Jee Hahn, Jose Ignacio Escrig, Brian Shing & Anjan Debnath. (2020) In Vitro Effect of Pitavastatin and Its Synergistic Activity with Isavuconazole against Acanthamoeba castellanii. Pathogens 9:9, pages 681.
Crossref
Crossref
Wilasinee Dunkoksung, Nontima Vardhanabhuti, Pongpun Siripong & Suree Jianmongkol. (2019) Rhinacanthin-C Mediated Herb-Drug Interactions with Drug Transporters and Phase I Drug-Metabolizing Enzymes. Drug Metabolism and Disposition 47:10, pages 1040-1049.
Crossref
Crossref
Jie Yang, Junichi Hasegawa, Yusuke Endo, Kazuhiko Iitsuka, Miwa Yamamoto & Akiko Matsuda. (2019) Pharmacokinetic Drug Interaction Between Rosuvastatin and Tanjin in Healthy Volunteers and Rats. Yonago Acta Medica 62:1, pages 077-084.
Crossref
Crossref
José Pablo Werba, Shingen Misaka, Monica Gianna Giroli, Kenju Shimomura, Manuela Amato, Niccolò Simonelli, Lorenzo Vigo & Elena Tremoli. (2018) Update of green tea interactions with cardiovascular drugs and putative mechanisms. Journal of Food and Drug Analysis 26:2, pages S72-S77.
Crossref
Crossref
Elena Arrigoni, Marzia Del Re, Leonardo Fidilio, Stefano Fogli, Romano Danesi & Antonello Di Paolo. (2017) Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins. International Journal of Molecular Sciences 18:1, pages 104.
Crossref
Crossref
Bianca M. Liederer, Xingrong Liu, Simon Wong & Daniel R. Mudra. 2017. Translating Molecules into Medicines. Translating Molecules into Medicines
165
230
.
Miao Hu, Hon-Kit Lee, Kenneth K. W. To, Benny S. P. Fok, Siu-Kwan Wo, Chung-Shun Ho, Chun-Kwok Wong, Zhong Zuo, Thomas Y. K. Chan, Juliana C. N. Chan & Brian Tomlinson. (2016) Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin. European Journal of Clinical Pharmacology 72:12, pages 1471-1478.
Crossref
Crossref
Xue Lin, RuiYi Xu, Ligang Fang, Wei Chen, Dayi Hu, Shuiping Zhao, Yongjun Wang, Jihu Li & Xiaowei Yan. (2016) Factors influencing low-density lipoprotein cholesterol target achievement in primary care — Results from DYSIS China. International Journal of Cardiology 222, pages 51-56.
Crossref
Crossref
Leonardo Calza, Vincenzo Colangeli, Roberto Manfredi, Isabella Bon, Maria Carla Re & Pierluigi Viale. (2016) Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients. Journal of Antimicrobial Chemotherapy 71:6, pages 1451-1465.
Crossref
Crossref
Jeffrey E. Alfonsi, Robert A. Hegele & Steven E. Gryn. (2016) Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?. Current Atherosclerosis Reports 18:5.
Crossref
Crossref
Mark A. MoyadMark A. Moyad. 2016. Integrative Medicine for Breast Cancer. Integrative Medicine for Breast Cancer
141
171
.
Lucyna Matusewicz, Justyna Meissner, Monika Toporkiewicz & Aleksander F. Sikorski. (2015) The effect of statins on cancer cells—review. Tumor Biology 36:7, pages 4889-4904.
Crossref
Crossref